These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 37974107)

  • 21. The integrated single-cell analysis developed an immunogenic cell death signature to predict lung adenocarcinoma prognosis and immunotherapy.
    Zhang P; Zhang H; Tang J; Ren Q; Zhang J; Chi H; Xiong J; Gong X; Wang W; Lin H; Li J; Huang C
    Aging (Albany NY); 2023 Oct; 15(19):10305-10329. PubMed ID: 37796202
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exploring the immune landscape and drug prediction of an M2 tumor-associated macrophage-related gene signature in EGFR-negative lung adenocarcinoma.
    Huang Y; Zhang Y; Duan X; Hou R; Wang Q; Shi J
    Thorac Cancer; 2024 Jul; 15(21):1626-1637. PubMed ID: 38886907
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of a combined hypoxia and lactate metabolism prognostic signature in lung adenocarcinoma.
    Sun J; Jiang R; Hou L; Wang L; Li M; Dong H; Dong N; Lin Y; Zhu Z; Zhang G; Zhang Y
    BMC Pulm Med; 2024 Jul; 24(1):323. PubMed ID: 38965505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of novel gene signature for lung adenocarcinoma by machine learning to predict immunotherapy and prognosis.
    Shu J; Jiang J; Zhao G
    Front Immunol; 2023; 14():1177847. PubMed ID: 37583701
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An ICD-Associated DAMP Gene signature predicts survival and immunotherapy response of patients with lung adenocarcinoma.
    Wu Y; Li K; Liang S; Lou X; Li Y; Xu D; Wu Y; Wang Y; Cui W
    Respir Res; 2023 May; 24(1):142. PubMed ID: 37259066
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Machine-learning and combined analysis of single-cell and bulk-RNA sequencing identified a DC gene signature to predict prognosis and immunotherapy response for patients with lung adenocarcinoma.
    Zhang L; Guan M; Zhang X; Yu F; Lai F
    J Cancer Res Clin Oncol; 2023 Nov; 149(15):13553-13574. PubMed ID: 37507593
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Single-cell sequencing analysis and transcriptome analysis constructed the macrophage related gene-related signature in lung adenocarcinoma and verified by an independent cohort.
    Li R; Tong R; Zhang Z; Deng M; Wang T; Hou G
    Genomics; 2022 Nov; 114(6):110520. PubMed ID: 36372305
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel signature predicts prognosis and immunotherapy in lung adenocarcinoma based on cancer-associated fibroblasts.
    Ren Q; Zhang P; Lin H; Feng Y; Chi H; Zhang X; Xia Z; Cai H; Yu Y
    Front Immunol; 2023; 14():1201573. PubMed ID: 37325647
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug resistance related genes in lung adenocarcinoma predict patient prognosis and influence the tumor microenvironment.
    Yu H; Zhang W; Xu XR; Chen S
    Sci Rep; 2023 Jun; 13(1):9682. PubMed ID: 37322027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multi‑omics identification of a signature based on malignant cell-associated ligand-receptor genes for lung adenocarcinoma.
    Xu S; Chen X; Ying H; Chen J; Ye M; Lin Z; Zhang X; Shen T; Li Z; Zheng Y; Zhang D; Ke Y; Chen Z; Lu Z
    BMC Cancer; 2024 Sep; 24(1):1138. PubMed ID: 39267056
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic and onco-immunological value of immune-related eRNAs-driven genes in lung adenocarcinoma.
    Wu X; Zhao X; Zhou C; Wei N; Xu Z; Zhang X
    J Cancer Res Clin Oncol; 2024 Apr; 150(4):188. PubMed ID: 38602568
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma.
    Zuo S; Wei M; Wang S; Dong J; Wei J
    Front Immunol; 2020; 11():1218. PubMed ID: 32714316
    [No Abstract]   [Full Text] [Related]  

  • 33. Prognostic value of CCR2 as an immune indicator in lung adenocarcinoma: A study based on tumor-infiltrating immune cell analysis.
    Wan Y; Wang X; Liu T; Fan T; Zhang Z; Wang B; Zhang B; Tian Z; Mao T; Gong Z; Zhang L
    Cancer Med; 2021 Jun; 10(12):4150-4163. PubMed ID: 33949150
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of an invasion score based on metastasis-related pathway activity profiles for identifying invasive molecular subtypes of lung adenocarcinoma.
    Han T; Liu Y; Zhou J; Guo J; Xing Y; Xie J; Bai Y; Wu J; Hu D
    Sci Rep; 2024 Jan; 14(1):1692. PubMed ID: 38243040
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
    Li N; Wang J; Zhan X
    Front Immunol; 2021; 12():752643. PubMed ID: 34887858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Single-cell dissection reveals the role of aggrephagy patterns in tumor microenvironment components aiding predicting prognosis and immunotherapy on lung adenocarcinoma.
    Sun X; Meng F; Nong M; Fang H; Lu C; Wang Y; Zhang P
    Aging (Albany NY); 2023 Dec; 15(23):14333-14371. PubMed ID: 38095634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Single-cell transcriptome analysis revealed a suppressive tumor immune microenvironment in EGFR mutant lung adenocarcinoma.
    Yang L; He YT; Dong S; Wei XW; Chen ZH; Zhang B; Chen WD; Yang XR; Wang F; Shang XM; Zhong WZ; Wu YL; Zhou Q
    J Immunother Cancer; 2022 Jan; 10(2):. PubMed ID: 35140113
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Construction of RNA Methylation Modification-immune-related lncRNA Molecular Subtypes and Prognostic Scoring System in Lung Adenocarcinoma.
    Wang J; Shu J
    Curr Med Chem; 2024; 31(12):1539-1560. PubMed ID: 37680151
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comprehensive analysis of co-expressed genes with TDP-43: prognostic and therapeutic potential in lung adenocarcinoma.
    Zhang H; Lin J; Yahaya BH
    J Cancer Res Clin Oncol; 2024 Jan; 150(2):44. PubMed ID: 38281298
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Landscape and dynamics of single tumor and immune cells in early and advanced-stage lung adenocarcinoma.
    Chen Z; Huang Y; Hu Z; Zhao M; Li M; Bi G; Zheng Y; Liang J; Lu T; Jiang W; Xu S; Zhan C; Xi J; Wang Q; Tan L
    Clin Transl Med; 2021 Mar; 11(3):e350. PubMed ID: 33783985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.